What Are the Key B7-33 Peptide Benefits for Cardioprotection?

B7-33 peptide benefits help protect the heart in lab studies. This lab-made peptide fights heart disease in many ways. It works by targeting special parts of heart cells that keep the heart safe.

B7-33 works with relaxin paths to reduce heart scarring. It also helps blood flow better to hurt heart tissue. Lab tests show B7-33 may stop scar tissue from forming after heart attacks.

This makes it useful for learning about heart health. These peptides are for lab use only and not for human use.

Explore B7-33 Peptide from Peptide Works, a synthetic relaxin analog studied for reducing cardiac fibrosis and improving heart tissue repair.

How Does B7-33 Target Cardiac Fibrosis Mechanisms?

B7-33 targets cardiac fibrosis by activating the relaxin family peptide receptor 1 (RXFP1). This signaling reduces the activity of cardiac fibroblasts, the cells that produce excess collagen after heart injury. Studies also show B7-33 increases matrix metalloproteinase-2 (MMP-2), an enzyme that breaks down excess collagen and supports extracellular matrix remodeling.

Preclinical studies found that B7-33 reduced cardiac fibrosis and improved heart structure after myocardial injury. The peptide works through selective ERK1/2 signaling which is linked to its anti-fibrotic effects.

These findings suggest B7-33 may help limit scar tissue formation and support healthy cardiac remodeling in experimental models.

Why Does Collagen Control Matter for Heart Health?

Collagen control is key to how well the heart heals after damage. B7-33 peptide benefits help manage this protein that forms the heart’s structure. When the heart gets hurt during an infarction, collagen must rebuild in the right way.

Too much collagen makes stiff scars that hurt heart function. Too little collagen makes weak spots that can tear. B7-33 works through specific pathways to keep collagen balanced.

It helps primary cardiomyocytes work with collagen properly. This process controls the matrix that holds heart cells together. Good collagen control stops harmful inflammation while keeping the heart strong and flexible.

How Does B7-33 Reduce Heart Inflammation?

Heart inflammation is a major problem that B7-33 peptide benefits address through immune responses control. The peptide targets receptors that stop chronic inflammation from hurting blood vessels and heart muscle.

B7-33 helps reduce endoplasmic reticulum stress in heart cells, which causes harmful swelling. It works by changing kinase activation that controls inflammatory signals. The peptide also helps prevent high blood pressure by keeping blood vessels healthy.

For chronic neuropathic pain AICAR peptide works by targeting NAD pathways that control nerve inflammation. This creates potential benefits for managing pain conditions that affect multiple organ systems.

Discover AICAR Peptide from Peptide Works, a research compound that targets cellular energy and NAD pathways to support nerve and heart health.

What Is Endoplasmic Reticulum Stress in Heart Cells?

The endoplasmic reticulum is a part inside heart cells that makes proteins and keeps them folded right. When heart cells get hurt, this system gets damaged and creates stress.

B7-33 peptide benefits help fix this problem by stopping the unfolded protein response that hurts cells. This stress makes heart rate go up and can lead to acute heart failure if not fixed.

The peptide hormone works by helping cells handle stress better and keep making good proteins. When the endoplasmic reticulum works right, heart cells stay healthy even during hard times.

This process is key for keeping cardiomyocytes alive after heart attacks and other cardiac events.

How Does B7-33 Protect Cardiomyocytes from Damage?

Cardiomyocytes are the main muscle cells that make the heart beat and pump blood. B7-33 peptide benefits protect these vital cells by stopping damage at the cellular level.

Laboratory studies show the peptide has pleiotropic effects, meaning it helps cells in many different ways at once. B7-33 keeps cardiomyocytes alive during heart attacks by helping them use energy better and stay strong.

Research using polymerase chain reaction analysis demonstrates how well these heart muscle cells survive with B7-33 treatment. The peptide also works with human relaxin to keep cell membranes healthy and flexible.

Further research shows these heart muscle cells can recover faster and work better when protected by B7-33.

What Are the Pleiotropic Effects of B7-33 on Heart Cells?

Pleiotropic effects mean a peptide produces several biological effects through different cellular pathways. Studies show B7-33 activates the relaxin family peptide receptor 1 (RXFP1) and selectively stimulates ERK1/2 signaling.

This signaling promotes matrix metalloproteinase-2 (MMP-2), which helps break down excess collagen and supports healthy tissue remodeling.

Research also shows B7-33 reduced cardiac fibrosis, limited infarct size and preserved heart structure in experimental models after myocardial injury. Studies found the peptide reduced markers linked to cellular stress and injury in cardiomyocytes.

These combined actions explain the pleiotropic effects of B7-33 on heart cells in cardiovascular research.

How Does B7-33 Support Healthy Immune Responses in Heart Disease?

Heart disease often involves harmful immune activity that damages cardiovascular tissue. B7-33 peptide benefits help balance immune responses to protect against myocardial infarction through controlled activation of protective pathways.

Laboratory findings show the peptide works by managing immune cells that otherwise trigger vessel damage. B7-33 helps prevent immune-related cardiac events by supporting proper cardiac function during stress.

The compound also works with the body’s natural systems. It helps immune cells work with heart tissue instead of attacking it. This immune-balancing effect may make B7-33 valuable for autoimmune heart conditions.

The Future of Peptides in Chronic Neuropathic Pain

Looking ahead, peptides like B7-33 and AICAR may lead to new ways to study chronic neuropathic pain. These compounds may do more than support cardiovascular research. Studies suggest they may also help target nerve pain through similar cellular pathways.

Peptide Works continues to provide high-quality compounds for research in this field. As more laboratory studies are completed, these peptides may help guide new and more targeted approaches for chronic neuropathic pain management.

All peptides and compounds mentioned are strictly for research purposes only and not for human use.

References:

(1) Devarakonda T, Mauro AG, Guzman G, Hovsepian S, Cain C, Das A, Praveen P, Hossain MA, Salloum FN. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice. J Am Heart Assoc. 2020 Apr 21;9(8):e015748.

(2) Maruyama K, Imanaka-Yoshida K. The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress. Int J Mol Sci. 2022 Feb 27;23(5):2617.

(3) Chow BS, Chew EG, Zhao C, Bathgate RA, Hewitson TD, Samuel CS. Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS. PLoS One. 2012;7(8):e42714.

(4) Valle Raleigh J, Mauro AG, Devarakonda T, Marchetti C, et al. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism. Cardiovasc Res. 2017 May 1;113(6):609-619.